Hurvitz Chaim - Insider Non-Derivative Transactions at NRX Pharmaceuticals, Inc. (NRXP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 30, 2023, Hurvitz Chaim's relationship to NRX Pharmaceuticals, Inc. (NRXP) is Director, and currently has 570,000 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NRXP insiders.
Data Source: SEC.
Hurvitz Chaim - Insider Non-Derivative Transactions at NRXP
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 31, 2023 | P -- (Common Stock, par value $0.001 per share) | 70000 | 0.29 | 570000 |